学科主题临床医学
Protection against aminoglycoside-induced ototoxicity by regulated AAV vector-mediated GDNF gene transfer into the cochlea
Liu, Yuhe2; Okada, Takashi1; Shimazaki, Kuniko; Sheykholeslami, Kianoush3; Nomoto, Tatsuya; Muramatsu, Shin-Ichi; Mizukami, Hiroaki; Kume, Akihiro; Xiao, Shuifang2; Ichimura, Keiichi; Ozawa, Keiya
刊名MOLECULAR THERAPY
2008-03-01
DOI10.1038/sj.mt.6300379
16期:3页:474-480
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Biotechnology & Applied Microbiology ; Genetics & Heredity ; Medicine, Research & Experimental
研究领域[WOS]Biotechnology & Applied Microbiology ; Genetics & Heredity ; Research & Experimental Medicine
关键词[WOS]RECOMBINANT ADENOASSOCIATED VIRUS ; EXPRESSION IN-VIVO ; CELL-LINE ; NEUROTROPHIC FACTOR ; TRANSGENE EXPRESSION ; HEARING-LOSS ; HAIR-CELLS ; NONHUMAN-PRIMATES ; TIGHT CONTROL ; VIRAL VECTOR
英文摘要

Since standard aminoglycoside treatment progressively causes hearing disturbance with hair cell degeneration, systemic use of the drugs is limited. Adeno-associated virus (AAV)-based vectors have been of great interest because they mediate stable transgene expression in a variety of postmitotic cells with minimal toxicity. In this study, we investigated the effects of regulated AAV1-mediated glial cell line-derived neurotrophic factor (GDNF) expression in the cochlea on aminoglycoside-induced damage. AAV1-based vectors encoding GDNF or vectors encoding GDNF with an rtTA2s- S2 Tet- on regulation system were directly microinjected into the rat cochleae through the round window at 5 x 10(10) genome copies/body. Seven days after the virus injection, a dose of 333 mg/kg of kanamycin was subcutaneously given twice daily for 12 consecutive days. GDNF expression in the cochlea was confirmed and successfully modulated by the Tet-on system. Monitoring of the auditory brain stem response revealed an improvement of cochlear function after GDNF transduction over the frequencies tested. Damaged spiral ganglion cells and hair cells were significantly reduced by GDNF expression. Our results suggest that AAV1-mediated expression of GDNF using a regulatedexpression system in the cochlea is a promising strategy to protect the cochlea from aminoglycoside-induced damage.

语种英语
WOS记录号WOS:000253548100007
引用统计
被引频次:20[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/55147
专题北京大学第一临床医学院_耳鼻咽喉头颈外科
作者单位1.Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mol Therapy, Tokyo 1878551, Japan
2.Peking Univ, Hosp 1, Dept Otolaryngol, Beijing 100871, Peoples R China
3.Northeastern Ohio Univ Coll Med & Pharm, Dept Neurobiol, Rootstown, OH 44272 USA
推荐引用方式
GB/T 7714
Liu, Yuhe,Okada, Takashi,Shimazaki, Kuniko,et al. Protection against aminoglycoside-induced ototoxicity by regulated AAV vector-mediated GDNF gene transfer into the cochlea[J]. MOLECULAR THERAPY,2008,16(3):474-480.
APA Liu, Yuhe.,Okada, Takashi.,Shimazaki, Kuniko.,Sheykholeslami, Kianoush.,Nomoto, Tatsuya.,...&Ozawa, Keiya.(2008).Protection against aminoglycoside-induced ototoxicity by regulated AAV vector-mediated GDNF gene transfer into the cochlea.MOLECULAR THERAPY,16(3),474-480.
MLA Liu, Yuhe,et al."Protection against aminoglycoside-induced ototoxicity by regulated AAV vector-mediated GDNF gene transfer into the cochlea".MOLECULAR THERAPY 16.3(2008):474-480.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Liu, Yuhe]的文章
[Okada, Takashi]的文章
[Shimazaki, Kuniko]的文章
百度学术
百度学术中相似的文章
[Liu, Yuhe]的文章
[Okada, Takashi]的文章
[Shimazaki, Kuniko]的文章
必应学术
必应学术中相似的文章
[Liu, Yuhe]的文章
[Okada, Takashi]的文章
[Shimazaki, Kuniko]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。